| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥326.93B | ¥316.05B | +3.4% |
| Operating Income | ¥6.13B | ¥7.62B | -19.5% |
| Share of Profit/Loss from Equity-Method Investments | - | - | - |
| Ordinary Income | ¥7.16B | ¥8.52B | -16.0% |
| Net Income | ¥4.78B | ¥6.24B | -23.3% |
| ROE | 1.6% | 2.1% | - |
Q1 of the fiscal year ending March 2027 saw higher revenue but lower profit, with margins compressed by a decline in the gross margin and an increase in the SG&A ratio. Revenue was ¥326.93B (+3.4% YoY), Operating Income was ¥6.13B (-19.5%), Ordinary Income was ¥7.16B (-16.0%), and Net Income was ¥4.78B (-23.3%). The benefit of higher revenue was offset by rising costs and increased expenses, resulting in lower profit at every level compared with the previous year. In addition, due to the parent company’s tender offer and the planned delisting, the Company is in an unusual situation in which it has not disclosed earnings forecasts and has resolved not to pay dividends for the current period.
【Revenue】Revenue was ¥326.93B, representing a 3.4% increase YoY. Although segment-level disclosures are not available, demand for existing businesses appears to have remained firm compared with the previous year.
【Profit and Loss】Operating Income was ¥6.13B (¥7.62B in the previous year, -19.5%), and the operating margin declined to 1.9% from 2.4% in the previous year. The gross margin declined to 7.2% (7.5% in the previous year), while the SG&A ratio rose to 5.3% (5.1% in the previous year). Cost pressures exceeding the benefit of higher revenue were the primary cause of the decline in Operating Income. Ordinary Income was ¥7.16B (-16.0%), supported by ¥1.06B in non-operating income, including ¥0.19B in dividend income, narrowing the decline from Operating Income somewhat. Extraordinary losses were limited to ¥0.16B, including losses on disposal of fixed assets, and the impact of temporary factors on earnings was limited. Against Profit Before Tax of ¥7.00B, income taxes and other taxes of ¥2.21B were recorded, resulting in an effective tax rate of 31.6% and Net Income of ¥4.78B (-23.3%). In conclusion, the Company posted higher revenue but lower profit.
【Profitability】The operating margin was 1.9%, down from 2.4% in the previous year, while the net profit margin also declined to 1.5% from 2.0% in the previous year. ROE was 1.6%, primarily due to lower profitability.【Cash Flow Quality】Operating Cash Flow (OCF) was -¥11.52B, representing a significant divergence from Net Income of ¥4.78B. EBITDA, calculated by adding depreciation and amortization of ¥1.61B to Operating Income, was ¥7.75B. OCF was below this level, confirming weak cash conversion. 【Investment Efficiency】The total asset turnover ratio (Revenue/Total Assets) for the quarter was approximately 0.62x. Combined with an Equity Ratio of 57.0%, this resulted in ROE of 1.6%.【Financial Soundness】The Equity Ratio was 57.0% (56.7% in the previous year), remaining almost flat and at a high level. Current Assets of ¥385.45B compared with Current Liabilities of ¥214.96B resulted in a current ratio exceeding 179%, providing a solid liquidity cushion. Non-current liabilities were limited to ¥11.23B, and pressure from long-term debt was limited.
Operating Cash Flow (OCF) was -¥11.52B, with the deficit expanding from -¥6.00B in the same period of the previous year. The primary factors were increases of ¥13.90B in accounts receivable and ¥2.71B in inventories, which could not be fully offset by the ¥1.26B increase in trade payables. Investing Cash Flow was -¥3.00B, primarily reflecting capital expenditures of ¥2.98B. Financing Cash Flow was -¥4.64B, including dividend payments and share repurchases of ¥0.77B. As a result, Free Cash Flow was -¥14.52B, indicating that cash generated from operating activities was insufficient to cover investment and shareholder return activities. Cash and deposits declined by ¥19.16B from the beginning of the period to ¥64.12B. The increase in working capital, which placed pressure on liquidity, was the defining feature of cash flow during the quarter.
Ordinary Income of ¥7.16B comprised Operating Income of ¥6.13B, plus ¥1.06B in non-operating income—including ¥0.19B in dividend income and ¥0.32B in other non-operating income—less ¥0.03B in non-operating expenses. Non-core income thus provided a modest boost to Ordinary Income. Extraordinary items were limited, consisting of extraordinary income of ¥0.00B and extraordinary losses of ¥0.16B, including losses on disposal of fixed assets. Their impact on Profit Before Tax of ¥7.00B was limited, and there is no indication that temporary factors materially affected earnings. Meanwhile, after deducting income taxes and other taxes of ¥2.21B, the effective tax rate was 31.6%, a relatively substantial level that widened the reduction from Profit Before Tax to Net Income. Given that OCF was significantly below Net Income, the Company’s ability to generate cash supporting Net Income was weak. Accordingly, earnings quality should be assessed after considering the impact of accruals arising from the increase in working capital.
No earnings forecast for the fiscal year ending March 2027 has been disclosed. Following a tender offer by the parent company, Medipal Holdings Corporation, and a series of subsequent procedures, the Company’s shares are scheduled to be delisted. Accordingly, disclosure of the Full Year earnings forecast has been withheld.
It has been resolved that no dividends will be paid for either the end of Q2 or the fiscal year-end of the fiscal year ending March 2027. This is a response to the parent company’s tender offer and the planned subsequent delisting, and differs in nature from the Company’s ordinary-period dividend policy. Meanwhile, share repurchases of ¥0.77B were conducted, constituting shareholder returns without dividend payments. Given Free Cash Flow of -¥14.52B, the share repurchases during the quarter appear to have been funded by cash on hand rather than cash generated from operating activities.
Declining profitability: The gross margin was 7.2% (7.5% in the previous year), the SG&A ratio was 5.3% (5.1% in the previous year), and the operating margin declined to 1.9% (2.4% in the previous year). The key focus will be whether margin pressure from both costs and expenses continues.
Declining cash generation due to increased working capital: Accounts receivable increased by ¥13.90B, while inventories increased by ¥2.71B, resulting in OCF of -¥11.52B. The ¥1.26B increase in trade payables was insufficient to offset these increases, requiring monitoring of liquidity trends.
High effective tax rate: Income taxes and other taxes of ¥2.21B were recorded against Profit Before Tax of ¥7.00B, resulting in an effective tax rate of 31.6%. This factor widened the reduction from Ordinary Income to Net Income.
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 1.9% | 4.3% (1.7%–6.9%) | -2.4pt |
| Net Profit Margin | 1.5% | 3.8% (1.5%–5.1%) | -2.3pt |
Both the operating margin and net profit margin were below the industry median, placing the Company’s profitability in the lower tier of the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 3.4% | 3.1% (-0.6%–11.7%) | +0.3pt |
The Revenue growth rate was slightly above the industry median, indicating an approximately average level of revenue growth within the industry.
※Source: Compiled by the Company
The 1.9% operating margin was below the industry median of 4.3% (Delta -2.4pt). The defining feature of the current period was margin pressure from both the decline in the gross margin and the increase in the SG&A ratio.
OCF was -¥11.52B, representing a significant divergence from Net Income of ¥4.78B. Increases in accounts receivable and inventories reduced cash generation.
Due to the parent company’s tender offer and the planned delisting, the Company did not disclose an earnings forecast and resolved not to pay dividends for the current period. Its capital policy and disclosure framework are therefore operating under circumstances different from those of an ordinary period.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.
---End of Report---
These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Historical values are computed retrospectively using current guidance-achievement statistics.